SC
BIIB icon

Slow Capital’s Biogen BIIB Stock Holding History

Slow Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,067
Closed -$1.49M – 173
2020
Q4 		$1.49M Buy
6,067
+130
+2% +$33.5K 0.36% 104
2020
Q3 		$1.69M Buy
5,937
+306
+5% +$85.3K 0.46% 87
2020
Q2 		$1.51M Buy
5,631
+27
+0.5% +$8.12K 0.44% 83
2020
Q1 		$1.77M Buy
5,604
+157
+3% +$47.6K 0.67% 49
2019
Q4 		$1.62M Buy
5,447
+190
+4% +$52.7K 0.5% 73
2019
Q3 		$1.22M Buy
5,257
+4,105
+356% +$956K 0.43% 91
2019
Q2 		$269K Buy
1,152
+271
+31% +$62.6K 0.11% 157
2019
Q1 		$208K Sell
881
-738
-46% -$232K 0.08% 160
2018
Q4 		$487K Buy
1,619
+165
+11% +$52.7K 0.23% 118
2018
Q3 		$514K Buy
1,454
+67
+5% +$23.1K 0.23% 118
2018
Q2 		$403K Sell
1,387
-112
-7% -$31.5K 0.2% 119
2018
Q1 		$411K Buy
1,499
+250
+20% +$77.6K 0.18% 122
2017
Q4 		$397K Buy
+1,249
New +$401K 0.21% 115

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Slow Capital's BIIB Position: Q1 2021 in Review

Slow Capital sold out of Biogen (BIIB) in Q1 2021, closing a stake of 6,067 shares — an estimated $1.49M sold.

Slow Capital first reported a position in BIIB in Q4 2017 and held it in 13 quarters. The position peaked at $1.77M in Q1 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Slow Capital reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Slow Capital sold 6,067 Biogen shares in Q1 2021, an estimated $1.49M.
  • Slow Capital first reported a position in Biogen in Q4 2017 and held it in 13 quarters.
  • Slow Capital's Biogen position peaked at $1.77M in Q1 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Slow Capital's 13F filing for Q1 2021, filed 5 May 2021.